VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Change in Account Payables came in at -$86008.0 in Q3 2026, down 1267.64% YoY from $7366.0 in Q3 2025, and down 186.15% on a QoQ basis from $99835.0 in Q2 2026.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Change in Account Payables across 3 years of filings, most recently posting -$86008.0 for Q3 2026.
- Change in Account Payables for Q3 2026 came in at -$86008.0, down 1267.64% year-over-year; the trailing twelve-month figure through Jul 2026 was $115439.0 (up 3118.8% YoY), and the FY2026 annual result was $208813.0, up 4123.37% from the prior year.
- Change in Account Payables for Q3 2026 stood at -$86008.0, down from $99835.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $161084.0 in Q4 2025 and bottomed at -$86008.0 in Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 60.59 Mn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 3.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | - |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | - |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 15.68 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | -10.16 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | -11.86 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | - |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -86,008.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 99,835.00 |
| Jan 31, 2026 | -59,472.00 |
| Apr 30, 2025 | -5,190.00 |
| Oct 31, 2017 | -6,000.00 |